PRCT

SEC source: 0001628280-24-048105 · wk-form4_1731706118.xml · nonDerivative · entry 3

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 236,535

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.31 to $95.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-048105 · wk-form4_1731706118.xml · nonDerivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 245,936

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.30 to $94.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-048105 · wk-form4_1731706118.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 247,936

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.26 to $93.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 15

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 164,363

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 14

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 164,863

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.78 to $96.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 13

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 175,099

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.78 to $95.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 12

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 191,371

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.75 to $94.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 11

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 198,363

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.09 to $98.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 10

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 202,132

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.07 to $98.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 9

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 219,282

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.07 to $97.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 8

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 221,960

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.07 to $96.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 7

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 231,363

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.94 to $98.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 6

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 233,554

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.91 to $97.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 5

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 245,041

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.91 to $96.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 4

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 256,797

F6 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.64 to $95.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

F4 · balance_after: Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

F8 · balance_after: Includes shares previously held indirectly through Mallard Fund, L.P., which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

F9 · balance_after: Includes shares previously held indirectly through Kestrel Fund, L.P., which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

F10 · ownership.nature: Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by The 2:22 DNA Trust except to the extent of any pecuniary interest therein.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 3

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Kestrel Fund, L.P.

Disclosed balance after: 0

F5 · kind: On November 5, 2024, Kestrel Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 3,316 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F4 · balance_after: Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

F5 · balance_after: On November 5, 2024, Kestrel Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 3,316 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F2 · ownership.nature: CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the "CPMG Funds"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 2

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · Mallard Fund, L.P

Disclosed balance after: 0

F3 · kind: On November 5, 2024, Mallard Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 8,511 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F3 · balance_after: On November 5, 2024, Mallard Fund, L.P. distributed all of its remaining shares on a pro rata basis, for no consideration, including 8,511 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F4 · balance_after: Includes shares previously held indirectly through White Tailed Ptarmigan, LP, which were distributed on a pro rata basis, for no consideration, on November 5, 2024, in a transaction exempt from Section 16 under Rules 16a-9 and 16a-13.

F2 · ownership.nature: CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the "CPMG Funds"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein.

SEC source: 0001628280-24-046469 · wk-form4_1731027936.xml · nonDerivative · entry 1

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By White Tailed Ptarmigan, LP

Disclosed balance after: 0

F1 · kind: On November 5, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 51,245 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F1 · balance_after: On November 5, 2024, White Tailed Ptarmigan, LP distributed shares on a pro rata basis, for no consideration, including 51,245 shares that were distributed in transactions exempt from Section 16 under Rule 16a-13.

F2 · ownership.nature: CPMG, Inc. is the general partner and investment manager of each of White Tailed Ptarmigan, LP, Kestrel Fund, L.P. and Mallard Fund, L.P. (collectively, the "CPMG Funds"). Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by the CPMG Funds. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by the CPMG Funds except to the extent of any pecuniary interest therein.

SEC source: 0001628280-24-044595 · wk-form4_1730408825.xml · derivative · entry 3

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 961,148

Underlying: Common Stock · 288,461 shares

Expires 2030-02-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The Stock option was granted on February 20, 2020, and vested over a four year period.

SEC source: 0001628280-24-044595 · wk-form4_1730408825.xml · nonDerivative · entry 2

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 258,445

F1 · kind: Shares sold on October 30, 2024, pursuant to the underwriters exercise of an option to purchase shares as detailed in the prospectus supplement filed with the SEC, dated October 29, 2024, pursuant to Rule 424(b)(5) and Registration No. 333-273569.

SEC source: 0001628280-24-044595 · wk-form4_1730408825.xml · nonDerivative · entry 1

Zadno Reza · CIK 0001632326 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 546,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · derivative · entry 5

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,160

Underlying: Common Stock · 25,000 shares

Expires 2029-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option was granted on December 12, 2019 and vested over a four year period.

SEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 4

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,096

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.56 to $73.87. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 3

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,022

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.56 to $73.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 2

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,137

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.56 to $72.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-043032 · wk-form4_1729196860.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,096

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · derivative · entry 7

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,160

Underlying: Common Stock · 9,083 shares

Expires 2029-12-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The Stock option was granted on December 12, 2019 and vested over a four year period.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · derivative · entry 6

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,917 shares

Expires 2028-10-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The Stock Option was granted on October 23, 2018 and vested over a four year period.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 5

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,096

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.34 to $83.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 4

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,496

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.30 to $83.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 3

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,473

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.30 to $82.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 2

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,096

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-24-040837 · wk-form4_1726696732.xml · nonDerivative · entry 1

Waters Kevin · CIK 0001653771 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,013

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 10

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 197,453

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.33 to $81.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 9

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 226,142

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.33 to $80.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 8

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 235,544

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.33 to $79.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 7

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 237,862

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.27 to $78.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 6

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 242,320

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.48 to $79.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 5

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 246,502

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.48 to $78.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 4

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 267,234

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.46 to $77.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 3

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 272,114

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.435 to $76.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 2

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 281,018

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.24 to $76.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-040284 · wk-form4_1726185775.xml · nonDerivative · entry 1

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 298,828

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.24 to $76.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 13

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 317,518

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.79 to $77.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 12

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 318,418

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.78 to $76.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 11

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 330,823

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.24 to $76.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 10

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 331,223

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.23 to $76.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 9

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By The 2:22 DNA Trust

Disclosed balance after: 354,387

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.23 to $75.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 8

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,543

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.33 to $76.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-24-039573 · wk-form4_1725578026.xml · nonDerivative · entry 7

Desai Antal Rohit · CIK 0001881616 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,743

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 30, 2024.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.25 to $76.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.